Single User License: $5500
Member Price: FREE
Use code SUMMER at checkout for 50% OFF
Already a member? Login to access this report free.
Report Highlights
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Report Includes
- 51 data tables and 39 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Analysis of global market trends, featuring historical revenue data for 2021-2023, estimated figures for 2024, forecasts for 2025, and projected CAGRs through 2029
- Identification of new opportunities, challenges and technological changes in the industry and a market share analysis by segment, product type, technology type, application, production method, and region
- Examination of the present and future strategies of companies in the market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Discussion of the applications for positron emission tomography (PET) and single photon emission computed tomography (SPECT)
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Analysis of the current market trends and forecast, R&D activity, product launches and regulatory elements
- Analysis of the key companies’ market shares, mergers & acquisitions, joint ventures and collaborations
- Profiles of the major players in the market, including Accuray Inc., Cardinal Health, Elekta, Novartis AG, and Siemens Healthineers AG
Report Scope
This report analyzes the global market for radiation therapy products (systems, software and services) and radiopharmaceuticals, in terms of quantitative and qualitative data, to help readers develop assess the market, business/growth strategies, and make informed business decisions regarding radiation therapy products and services and radiopharmaceuticals. BCC Research estimates market data for 2023 (the base year) and forecasts values for 2024 through 2029.
Radiation therapy market segmentation is based on product, technology, techniques, system type, application and region. Radiopharmaceuticals market segmentation is based on product, application, production method and region.
Industry growth drivers, restraints and opportunities in the radiation therapy and radiopharmaceutical market are also discussed. The report also reports on the competitive landscape of radiation therapy products, radiopharmaceutical markets and emerging trends. The latest new products, acquisitions, and collaborations related to the radiation therapy and radiopharmaceutical markets are also covered.
Report Synopsis
| Report Metrics | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||
| Forecast period considered | 2024-2029 | ||||||||
| Base year market size | $16.1 billion | ||||||||
| Market size forecast | $31.3 billion | ||||||||
| Growth rate | CAGR of 12.3% for the forecast period of 2024-2029 | ||||||||
| Units considered | $ Millions | ||||||||
| Segments covered | Segment, Product Type, Technology Type, Application, Production Method, and Region | ||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||
| Key Market Drivers |
|
||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global radiopharmaceuticals and therapeutics market should reach $28.5 billion by 2026 from $18.2 billion in 2021 at a compound annual growth rate (CAGR) of 9.4% for the forecast period of 2021 to 2026.
Report Includes
- 52 data tables and 72 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals, and nuclear medicines
- Estimation of the market size and analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, with projection of CAGR through 2026
- Analysis of new opportunities, challenges, and technological changes within the industry and highlights of the market potential by type, method, technology, application and region
- Assessment of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market, including Accuray Inc., Bayer Pharma AG, Cardinal Health, General Electric Co., Nordion Inc. and Siemens Healthineers AG
Report Highlights
The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.
Report Includes
- 94 data tables and 83 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
- Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Coverage of new products launches and product enhancement in the industry
- Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.
Report Highlights
The global radiotherapy market was valued at $6.4 billion in 2016. The market should reach $6.8 billion and $9.2 billion in 2017 and 2022, respectively; growing at a compound annual growth rate (CAGR) of 6.4% from 2017 to 2022.
Report Includes
- An overview of the global market for radiotherapy and related technologies and applications.
- Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.
- Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.
- Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
- Comprehensive company profiles of major players in the industry.
Report Highlights
The radiation therapy market totaled $5.4 billion in 2013 and $5.8 billion in 2014. The market is expected to reach $8.1 billion in 2019, a compound annual growth rate(CAGR) of 6.7%.
Report Includes
- An overview of the global market for radiotherapy and related technologies and applications
- Analyses of market trends, with data from 2013 and 2014, and projections of CAGRs through 2019
- Discussion of major factors driving the growth for nuclear medicine including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine
- Detailed information conerning major challenges the market faces including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes
- Analysis of the diagnostic applications for radiotherapy such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)
- Comprehensive company profiles of major players in the industry.
Related Reports
Monoclonal Antibodies for Oncology: Global Markets
The global market for monoclonal antibodies in oncology is estimated to grow from $76.2 billion in 2022 to more than $138.1 billion by 2027, with a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2022-2027.
Global Interventional Oncology Market
The global interventional oncology market should reach $3.1 billion by 2026 from $2.2 billion in 2021 at a compound annual growth rate (CAGR) of 7.0% for the forecast period of 2021 to 2026.
Global Nuclear Imaging Equipment Market
The global nuclear imaging equipment market should reach $4.9 billion by 2026 from $3.7 billion in 2021 at a compound annual growth rate (CAGR) of 5.7% for the forecast period of 2021 to 2026.
Artificial Intelligence (AI) in Cancer
The goal of this short study is to provide a detailed review of how AI is being applied in fighting cancer. The report will evaluate the utilization of various AI tools (e.g., machine learning, natural language processing, image processing, speech recognition) in diagnosis, therapy, research and development, and health management (e.g., patient data, insurance information, and hospital stay) as it relates to cancer. Also, emphasis will be given to the types of algorithms (e.g., artificial neural networks, deep learning) that have been developed so far in the field of cancer.
Recent Reports
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Top Trending Reports
Sensors: Technologies and Global Markets
The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.
Hydrogen Storage: Materials, Technologies and Global Markets
The global market for hydrogen storage materials and technologies is expected to grow from $5.3 billion in 2023 to $7.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Solid State Batteries: Global Markets
The global market for solid state batteries is estimated to increase from $274.0 million in 2023 to reach $1.7 billion by 2029, at a compound annual growth rate (CAGR) of 36.7% from 2024 through 2029.
Life Science Tools and Reagents: Global Markets
The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More